OLANDER CLINICAL CONSULTING 1 ApS: Financial statements 2019
CVR: 35532900
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
OLANDER CLINICAL CONSULTING 1 ApS (CVR 35532900) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -6,453 and a net result of DKK 22,119 compared with DKK 26,597 the year before. Equity in the 2019 report amounted to DKK 108,481. The solvency ratio was 76.4%.
- Gross Profit
- DKK -6,453
- Profit/Loss
- DKK 22,119
- Equity
- DKK 108,481
- Total Assets
- DKK 142,081
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -6K | 22K | 108K | - |
| 2018 | - | -8K | 27K | 116K | - |
| 2017 | - | -12K | 14K | 90K | - |
| 2016 | - | -9K | 21K | 75K | 0 |
| 2015 | - | -16K | -165K | 55K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
OLANDER CLINICAL CONSULTING 1 ApS has published its annual report for 2018. Gross profit came to DKK -7,561, and the net result was DKK 26,597.
About OLANDER CLINICAL CONSULTING 1 ApS
OLANDER CLINICAL CONSULTING 1 ApS is a Danish company of the type Anpartsselskab based in Snekkersten, founded in 2013. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. The company has 0 employees (2015). In 2025, the company reported a gross profit of DKK 38,365 and a net result of DKK 28,455 compared with DKK 30,979 the year before. Equity in the 2025 report amounted to DKK 167,137.